CRBRX
Price
$15.82
Change
+$0.09 (+0.57%)
Updated
Aug 21 closing price
Net Assets
2.47B
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

CRBRX vs FSMAX

CRBRX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CRBRX vs. FSMAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBRX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. CRBRX (2.48B). FSMAX pays higher dividends than CRBRX: FSMAX (0.50) vs CRBRX (0.00). CRBRX was incepted earlier than FSMAX: CRBRX (14 years) vs FSMAX (15 years). CRBRX (0.81) is less costly to investors than FSMAX (0.04). CRBRX is a more actively managed with annual turnover of: 78.00 vs. FSMAX (23.00). CRBRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. CRBRX (15.81). FSMAX return over 5 years is better than : 40.14 vs. CRBRX (-12.96).
CRBRXFSMAXCRBRX / FSMAX
Total Expense Ratio0.790.042,257%
Annual Report Gross Expense Ratio0.810.042,314%
Fund Existence14 years15 years-
Gain YTD9.25416.93755%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B40.1B6%
Annual Yield % from dividends0.000.50-
Returns for 1 year15.8123.6867%
Returns for 3 years41.7672.7457%
Returns for 5 years-12.9640.14-32%
Returns for 10 years-16.95134.49-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3